NSE · LALPATHLAB.NS
Dr. Lal PathLabs Limited
₹1,908.80-₹2.90 (-0.15%)
Dr. Lal PathLabs Limited’s quoted price sits in the upper half of its reported 52-week range, 6.37% below the high.
Loading market information…
BSE · ASPIRA.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 08:25 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Aspira Pathlab & Diagnostics Limited’s quoted price sits in the upper half of its reported 52-week range, 10.79% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Aspira Pathlab & Diagnostics Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Aspira Pathlab & Diagnostics Ltd. specializes in managing diagnostic centers and laboratories. The company performs an extensive range of pathological analyses, encompassing biochemistry, hematology, histopathology, microbiology, immunochemistry, immunology, virology, cytology, in addition to other pathological and radiological examinations. Their services also include corporate health solutions like on-site and remote employee health assessments, quick industry-specific screenings conducted at client locations, secure and private handling of employee data, and personalized packages tailored to specific industry requirements. Founded on July 3, 1973, the firm is headquartered in Navi Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:03 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,908.80-₹2.90 (-0.15%)
Dr. Lal PathLabs Limited’s quoted price sits in the upper half of its reported 52-week range, 6.37% below the high.
₹1,454.50-₹9.70 (-0.66%)
Vijaya Diagnostic Centre Limited’s quoted price sits in the upper half of its reported 52-week range, 8.73% below the high.
₹546.95-₹6.90 (-1.25%)
Metropolis Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 10.2% below the high.
₹454.00-₹61.50 (-11.93%)
Thyrocare Technologies Limited’s quoted price sits in the lower half of its reported 52-week range, 31.42% below the high.
₹316.20-₹3.35 (-1.05%)
Suraksha Diagnostic Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.17% below the high.
₹504.85+₹6.90 (+1.39%)
Krsnaa Diagnostics Limited’s quoted price sits in the lower half of its reported 52-week range, 39.76% below the high.
₹100.05-₹6.75 (-6.32%)
NG Industries Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.47% below the high.
₹13.00₹0.00 (0.0%)
Nidan Laboratories & Healthcare Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.79% below the high.
